Skinbiotherapeutics PLC (LON:SBTX) Chief Executive Officer Dr. Catherine O’Neill caught up with DirectorsTalk for an exclusive interview to discuss passing third party cytotoxicity tests, their scientific update to the market..
Rainbow Rare Earths Ltd (LON:RBW) Chief Executive Officer Martin Eales caught up with DirectorsTalk for an exclusive interview to discuss their final results, what has happened since the 30th June,..
Motorpoint Group Plc (LON:MOTR) has released a trading update this morning confirming a solid H1 performance with over 18% revenue growth. While we recognise there is an element of consumer..
ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are..
September SMMT data: private registrations -9.3% YOY and -3.9% YTD The SMMT (Society of Motor Manufacturers and Traders) has released data this morning confirming new car registrations in September of..
Motif Bio plc (LON:MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that new pre-clinical data with its investigational drug candidate iclaprim were presented today during..
